The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0*

@article{Silberstein2012TheSP,
  title={The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0*},
  author={Edward B. Silberstein and Abass Alavi and Helena R. Balon and Susan E. M. Clarke and Chaitanya R. Divgi and Michael J. Gelfand and Stanley J. Goldsmith and Hossein Jadvar and Carol S. Marcus and William H. Martin and J. A. Parker and Henry D Royal and Salil D. Sarkar and Michael Stabin and Alan D. Waxman},
  journal={The Journal of Nuclear Medicine},
  year={2012},
  volume={53},
  pages={1633 - 1651}
}
Key Method1UC Health University Hospital, Cincinnati, Ohio; 2Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; 3Beaumont Health System,Expand
Management of Challenging Radioiodine Treatment Protocols: A Case Series and Review of the Literature
TLDR
3 cases in which the standard 131I treatment protocol for thyroid cancer could not be used because of challenges in patients who cannot swallow pills, absorb iodine via the gastrointestinal tract, or eliminate RAI via the urine are presented. Expand
Use of radioiodine‐131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma
TLDR
The influence of surgical discipline, surgeon site, and volume on remnant thyroid tissue visualized on radioactive iodine‐131 (I‐131) scans after total thyroidectomy and I‐131 ablation in patients with well‐differentiated thyroid carcinomas is determined. Expand
Role of SPECT/CT, Versus Traditional Practices, in Individualizing Treatment of Thyroid Carcinoma
TLDR
The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology and its application in bone imaging is investigated. Expand
Radioiodine Therapy for Well-Differentiated Thyroid Cancer
Better understanding and more clinical evidence over the last two decades have accumulated for the use of radioiodine in the management algorithm of well-differentiated thyroid cancer, althoughExpand
Imaging thyroid disease: updates, imaging approach, and management pearls.
TLDR
5 common problems of the thyroid that require special consideration with regard to optimizing imaging strategies in a multidisciplinary and collaborative platform are focused on. Expand
Effect of Different 131I Dose Strategies for Treatment of Hyperthyroidism on Graves’ Ophthalmopathy
TLDR
The administration of 5.55 MBq/g of 131I has fewer ophthalmic complications compared with high fixed dose model and is more effective than low fixed dose strategy. Expand
Remnant Ablation, Adjuvant Treatment and Treatment of Locoregional Metastases with 131 I
The two major areas of controversy in the management of patients with differentiated thyroid cancer are when to administer an 131I therapy and, if administered, what should be the amount ofExpand
Conventional Radioiodine Therapy for Differentiated Thyroid Cancer.
TLDR
This article presents an overview of the use of radioactive iodine (131-I) in the treatment of patients with differentiated thyroid cancer and the MedStar Washington Hospital Center approach. Expand
Radioiodine Therapy of Hyperthyroidism
TLDR
In this chapter, indication, Patients preparation and precautions regarding radioiodine are outlined, and the procedures and the safety and side effects of this treatment are discussed. Expand
Radioiodine therapy in benign thyroid disorders. Evaluation of French nuclear medicine practices.
TLDR
The first nationwide French survey assessing the current practices in radioiodine treatment of hyperthyroidism shows that practices concerning the prescription of (131)I therapeutic doses are heterogeneous. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 173 REFERENCES
Testicular dose and fertility in men following I131 therapy for thyroid cancer
TLDR
Young adults with differentiated thyroid cancer are treated with high doses of radioiodine and have an excellent long‐term prognosis, but there is limited information on the effects on the gonads and fertility in male patients. Expand
Outcome of radioiodine‐131 therapy in hyperfunctioning thyroid nodules: a 20 years’ retrospective study
TLDR
Investigation of the risk of hypothyroidism after radioiodine (131I) treatment for hyperfunctioning thyroid nodules finds no evidence of an increased risk of the disease. Expand
Conjoint Statement of the SNM, ACNM, and ABNM on Credentialing and Delineation of Privileges for Therapeutic Procedures Using Radiopharmaceuticals
TLDR
The training requirements for the supervision and administration of therapeutic procedures using radiopharmaceuticals are not defined uniformly in the Accreditation Council of Graduate Medical Education program requirements for different specialties and these requirements should be uniform across ACGME specialty training requirements. Expand
The problem of the patient with thyroglobulin elevation but negative iodine scintigraphy: the TENIS syndrome.
TLDR
Doctors caring for patients with the TENIS syndrome are urged to enter them into clinical therapeutic studies whenever possible, and tyrosine kinase inhibitor drugs should be preferred to conventional chemotherapy at this time. Expand
Radioiodine treatment of solitary functioning thyroid nodules.
TLDR
It is concluded that a single fixed dose of 131I is a simple, effective treatment for a solitary toxic thyroid nodule and does not cause hypothyroidism. Expand
The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function.
TLDR
Very large goiters can be reduced by a third, on the average, with high dose 131I therapy without any initial clinically significant tracheal compression. Expand
Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group.
TLDR
While there was an elevated risk of thyroid cancer mortality following (131)I treatment, in absolute terms the excess number of deaths was small, and the underlying thyroid disease appeared to play a role, Overall, ( 131)I appears to be a safe therapy for hyperthyroidism. Expand
Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two?
TLDR
Nonincidental PTMC can have aggressive tumor features and disease recurrence similar to conventional PTC, and these tumors should be managed like any other papillary thyroid malignancy. Expand
The value of positron emission tomography (PET) in the management of patients with thyroid cancer.
TLDR
The majority of the published studies to date have used 18F-fluoro-deoxyglucose (FDG) as the PET isotope, and unless specifically noted, all references to PET scanning will imply that this tracer has been used. Expand
The nonimpact of thyroid stunning: remnant ablation rates in 131I-scanned and nonscanned individuals.
TLDR
This data indicates that initial treatment ablation rates in patients who received 111- to 185-MBq 131I diagnostic scans before ablative doses of 3700-7400 MBq are not significant and it is possible that the reported stunning phenomenon, specifically its impact in temporarily impairing tissue, has been overemphasized. Expand
...
1
2
3
4
5
...